TY - JOUR
AU1 - Shah, Rahman
AU2 - Rao, Sunil V.
AU3 - Latham, Samuel B.
AU4 - Kandzari, David E.
AB - 
Key PointsQuestionWhat is the optimal stent strategy for coronary intervention in patients with high risk for bleeding in whom a short course of dual antiplatelet therapy is preferred?
FindingsIn this meta-analysis of randomized clinical trials involving 3943 patients, we found that coronary intervention with drug-eluting stents decreased the risk for myocardial infarction, target vessel revascularization, ischemia-driven target lesion revascularization, and stent thrombosis compared with bare-metal stents used with 1 month of dual antiplatelet therapy.
MeaningIn patients with high bleeding risk, coronary interventions with drug-eluting stents optimized for biocompatibility appear preferable over those with bare-metal stents.

TI - Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy
JF - JAMA Cardiology
DO - 10.1001/jamacardio.2018.3551
DA - 2018-12-01
UR - https://www.deepdyve.com/lp/american-medical-association/efficacy-and-safety-of-drug-eluting-stents-optimized-for-N8ce3P1WmJ
SP - 1050
EP - 1059
VL - 3
IS - 11
DP - DeepDyve
ER -